Literature DB >> 25426219

Neuroimaging and renal ultrasound manifestations of Oculocerebrorenal syndrome of Lowe.

Andrew Mark Allmendinger1, Naman S Desai1, Alanna Teatom Burke2, Narayan Viswanadhan1, Sanjay Prabhu3.   

Abstract

Oculocerebrorenal syndrome of Lowe (OCRL) is a multisystem disorder characterized by congenital cataracts, hypotonia, and cognitive developmental delay with renal complications developing in the first few months of life. Clinical and laboratory findings of Lowe syndrome are well documented. Though a small number of case reports describe the neuroimaging features and the renal ultrasound manifestations of this disease, a comprehensive review of all the imaging manifestations has not been reported. The authors present a case of OCRL and review the neuroimaging and renal ultrasound manifestations of this multisystem disease.

Entities:  

Keywords:  Lowe Syndrome; MRI; oculocerebrorenal syndrome; renal nephrocalcinosis; ultrasound

Mesh:

Year:  2014        PMID: 25426219      PMCID: PMC4242147          DOI: 10.3941/jrcr.v8i10.1740

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  11 in total

1.  Lowe syndrome: proton mr spectroscopy, and diffusion mr imaging.

Authors:  R N Sener
Journal:  J Neuroradiol       Date:  2004-06       Impact factor: 3.447

2.  Periventricular white matter cystic lesions in Lowe (oculocerebrorenal) syndrome. A new MR finding.

Authors:  L A Demmer; F J Wippold; S B Dowton
Journal:  Pediatr Radiol       Date:  1992

3.  Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.

Authors:  C U LOWE; M TERREY; E A MacLACHLAN
Journal:  AMA Am J Dis Child       Date:  1952-02

4.  Central nervous system and renal investigations in patients with Lowe syndrome.

Authors:  S M Pueschel; A S Brem; P Nittoli
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

5.  Oculocerebrorenal syndrome of Lowe: magnetic resonance imaging findings in the first six years of life.

Authors:  Arnolfo de Carvalho-Neto; Sergio Eiji Ono; Georgina de Melo Cardoso; Mara Lucia Schmitz Ferreira Santos; Izabela Celidonio
Journal:  Arq Neuropsiquiatr       Date:  2009-06       Impact factor: 1.420

6.  Increased renal parenchymal echogenicity: causes in pediatric patients.

Authors:  R A Kraus; G Gaisie; L W Young
Journal:  Radiographics       Date:  1990-11       Impact factor: 5.333

7.  MR findings and neurologic manifestations in Lowe oculocerebrorenal syndrome.

Authors:  J Ono; K Harada; T Mano; T Yamamoto; S Okada
Journal:  Pediatr Neurol       Date:  1996-02       Impact factor: 3.372

8.  MR findings in oculocerebrorenal syndrome.

Authors:  W J Carroll; W W Woodruff; T E Cadman
Journal:  AJNR Am J Neuroradiol       Date:  1993 Mar-Apr       Impact factor: 3.825

9.  Tigroid pattern on magnetic resonance imaging in Lowe syndrome.

Authors:  Mehmet Ruhi Onur; Utku Senol; Ercan Mihçi; Ersin Lüleci
Journal:  J Clin Neurosci       Date:  2008-11-20       Impact factor: 1.961

Review 10.  Lowe syndrome.

Authors:  Mario Loi
Journal:  Orphanet J Rare Dis       Date:  2006-05-18       Impact factor: 4.123

View more
  7 in total

Review 1.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

2.  Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL.

Authors:  Maria Giovanna De Leo; Leopoldo Staiano; Mariella Vicinanza; Alessandro Luciani; Annamaria Carissimo; Margherita Mutarelli; Antonella Di Campli; Elena Polishchuk; Giuseppe Di Tullio; Valentina Morra; Elena Levtchenko; Francesca Oltrabella; Tobias Starborg; Michele Santoro; Diego Di Bernardo; Olivier Devuyst; Martin Lowe; Diego L Medina; Andrea Ballabio; Maria Antonietta De Matteis
Journal:  Nat Cell Biol       Date:  2016-07-11       Impact factor: 28.824

Review 3.  The oculocerebrorenal syndrome of Lowe: an update.

Authors:  Arend Bökenkamp; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

4.  Temper outbursts in Lowe syndrome: Characteristics, sequence, environmental context and comparison to Prader-Willi syndrome.

Authors:  Helen Cressey; Chris Oliver; Hayley Crawford; Jane Waite
Journal:  J Appl Res Intellect Disabil       Date:  2019-05-29

5.  Novel pathogenic OCRL mutations and genotype-phenotype analysis of Chinese children affected by oculocerebrorenal syndrome: two cases and a literature review.

Authors:  Yu Zhang; Linxia Deng; Xiaohong Chen; Yingjie Hu; Yaxian Chen; Kang Chen; Jianhua Zhou
Journal:  BMC Med Genomics       Date:  2021-09-06       Impact factor: 3.063

6.  dOCRL maintains immune cell quiescence by regulating endosomal traffic.

Authors:  Steven J Del Signore; Sarah A Biber; Katherine S Lehmann; Stephanie R Heimler; Benjamin H Rosenfeld; Tania L Eskin; Sean T Sweeney; Avital A Rodal
Journal:  PLoS Genet       Date:  2017-10-13       Impact factor: 5.917

7.  Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.

Authors:  Jesse Barnes; Franklin Salas; Ryan Mokhtari; Hedwig Dolstra; Erika Pedrosa; Herbert M Lachman
Journal:  Mol Autism       Date:  2018-08-15       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.